These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19491824)

  • 1. Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates.
    Rubenstein JH; Waljee AK; Jeter JM; Velayos FS; Ladabaum U; Higgins PD
    Am J Gastroenterol; 2009 Sep; 104(9):2222-32. PubMed ID: 19491824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis.
    Yen EF; Kane SV; Ladabaum U
    Am J Gastroenterol; 2008 Dec; 103(12):3094-105. PubMed ID: 18775007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.
    Herfarth H
    Dig Dis; 2012; 30 Suppl 2():55-9. PubMed ID: 23207933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluation.
    Negrón ME; Kaplan GG; Barkema HW; Eksteen B; Clement F; Manns BJ; Coward S; Panaccione R; Ghosh S; Heitman SJ
    Inflamm Bowel Dis; 2014 Nov; 20(11):2046-55. PubMed ID: 25230162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP; Card T; Logan RF; Leufkens HG
    Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 10. Will a 5-ASA a day keep the cancer (and dysplasia) away?
    Rubin DT; Lashner BA
    Am J Gastroenterol; 2005 Jun; 100(6):1354-6. PubMed ID: 15929769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer prevention in ulcerative colitis: a case-control study.
    Eaden J; Abrams K; Ekbom A; Jackson E; Mayberry J
    Aliment Pharmacol Ther; 2000 Feb; 14(2):145-53. PubMed ID: 10651654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerative colitis-associated colorectal cancer.
    Yashiro M
    World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical review of the evidence on 5-aminosalicilate for chemoprevention of colorectal cancer in ulcerative colitis: a methodological question.
    Margagnoni G; Pagnini C; Menasci F; Festa S; Delle Fave G
    Curr Clin Pharmacol; 2014 Feb; 9(1):84-90. PubMed ID: 24218994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motion - colonoscopic surveillance is more cost effective than colectomy in patients with ulcerative colitis: Arguments for the motion.
    Lashner BA
    Can J Gastroenterol; 2003 Feb; 17(2):119-21. PubMed ID: 12605250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colorectal cancer in ulcerative colitis.
    Croog VJ; Ullman TA; Itzkowitz SH
    Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis.
    Konijeti GG; Shrime MG; Ananthakrishnan AN; Chan AT
    Gastrointest Endosc; 2014 Mar; 79(3):455-65. PubMed ID: 24262637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
    Shaffer SR; Huang E; Patel S; Rubin DT
    Am J Gastroenterol; 2021 Jan; 116(1):125-133. PubMed ID: 32947317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.